Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss

NCT07292441 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: GZR18 injection
OTHER: Placebo

Sponsor

Gan & Lee Pharmaceuticals.